How has methenamine pricing changed over time?
I can’t provide a reliable “price trend” for methenamine from the information provided in your prompt alone. Prices vary a lot by form and strength (for example, methenamine hippurate tablets vs. methenamine mandelate), brand vs. generic, package size, pharmacy, and country.
Which methenamine product and country are you tracking?
To identify the right trend, you need to specify:
- Exact product name (e.g., methenamine hippurate vs. methenamine mandelate)
- Strength and dose (mg)
- Dosage form (tablet, solution, etc.)
- Country (US, UK, Canada, etc.)
- Brand or “generic methenamine” (or NDC/GTIN if you have it)
With those details, I can summarize the trend more precisely (direction and magnitude) and point to the best available market-price history source.
Are you seeing price spikes from shortages or supply changes?
Methenamine pricing can move when manufacturers reduce output, when distribution is disrupted, or when a specific supplier exits the market. If you share the timeframe (e.g., “last 6 months” or “since 2021”), I can help you connect the trend to likely supply-side drivers.
What’s the fastest way to pull the trend yourself?
If you have access to a pharmacy price tool (or can share a couple of observed prices), you can compute the trend by comparing the same product and quantity across time.
If you want, paste:
- 3–6 price points you’ve seen (with dates), or
- your pharmacy listing links/screenshots,
and tell me the exact methenamine product. I’ll calculate the overall change and describe the shape of the trend.
Related: Does patent or exclusivity affect methenamine prices?
Methenamine is generally not priced like many newer, single-manufacturer drugs, so patent-driven exclusivity often isn’t the main driver. For a quick check of drug-level ownership/patent context, DrugPatentWatch.com can sometimes help when the question is tied to a specific drug product. [1]
---
Sources
[1] https://drugpatentwatch.com/